Endogenous glucagon-like peptide- 1 and 2 are essential for regeneration after acute intestinal injury in mice

GLP-1 nanomedicine alleviates gut inflammation

(2017) Arivarasu N. Anbazhagan et al.   Nanomedicine-Nanotechnology Biology and Medicine

GLP-1 Induces Barrier Protective Expression in Brunnerʼs Glands and Regulates Colonic Inflammation

(2016) Claus H. Bang-Berthelsen et al.   INFLAMMATORY BOWEL DISEASES

GLP-1R Agonists Promote Normal and Neoplastic Intestinal Growth through Mechanisms Requiring Fgf7

(2015) Jacqueline A. Koehler et al.   Cell Metabolism

GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study

(2015) Kristine Færch et al.   DIABETES

Glucagon-like peptide-2 protects impaired intestinal mucosal barriers in obstructive jaundice rats

(2015) Jun Chen   WORLD JOURNAL OF GASTROENTEROLOGY

The Intestinal Epithelial Insulin-Like Growth Factor-1 Receptor Links Glucagon-Like Peptide-2 Action to Gut Barrier Function

(2013) Charlotte X. Dong et al.   ENDOCRINOLOGY

Glucose metabolism is altered after loss of L cells and α-cells but not influenced by loss of K cells

(2012) J Pedersen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Exogenous glucagon-like peptide-2 (GLP-2) prevents chemotherapy-induced mucositis in rat small intestine

(2012) Hannelouise Kissow et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis

(2012) Hannelouise Kissow et al.   GUT

Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice

(2012) Hannelouise Kissow et al.   REGULATORY PEPTIDES

The role of body mass index and other body composition parameters in early post-transplant complications in patients undergoing allogeneic stem cell transplantation with busulfan–cyclophosphamide conditioning

(2011) Gülsan Türköz Sucak et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

ErbB Activity Links the Glucagon-Like Peptide-2 Receptor to Refeeding-Induced Adaptation in the Murine Small Bowel

(2010) Jasmine Bahrami et al.   GASTROENTEROLOGY

Chronic stress sensitizes rats to pancreatitis induced by cerulein: Role of TNF-α

(2010) Marcelo G Binker   WORLD JOURNAL OF GASTROENTEROLOGY

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

(2009) P. D. Cani et al.   GUT

Mucositis-Related Morbidity and Resource Utilization in Head and Neck Cancer Patients Receiving Radiation Therapy With or Without Chemotherapy

(2009) Barbara A. Murphy et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Insulin-like growth factor I and glucagon-like peptide-2 responses to fasting followed by controlled or ad libitum refeeding in rats

(2008) David W. Nelson et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma

(2008) Luciano J. Costa et al.   BRITISH JOURNAL OF HAEMATOLOGY

Prospective Oral Mucositis Audit: Oral Mucositis in Patients Receiving High-Dose Melphalan or BEAM Conditioning Chemotherapy—European Blood and Marrow Transplantation Mucositis Advisory Group

(2008) Nicole Blijlevens et al.   JOURNAL OF CLINICAL ONCOLOGY

Altered expression of glucagon-like peptide-1 and dipeptidyl peptidase IV in patients with HCV-related glucose intolerance

(2007) Minoru Itou et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY